Abstract:We previously found that apolipoprotein E (APOE) ∊4 gene dose, reflecting three levels of genetic risk for late-onset Alzheimer's disease (AD), is associated with characteristic patterns of glucose hypometabolism and fibrillar amyloid-beta (Aβ) burden in cognitively normal older adults (Reiman et al, 2004; 2009). We have also introduced an automated algorithm, known as multi-modal partial least squares (MMPLS), to characterize the linkage between patterns in two or more complementary complex data sets from the same person on a voxel-by-voxel basis (Chen et al, 2009). In this study, we used MMPLS to characterize how APOE ∊4 gene dose is associated with patterns of cerebral hypometabolism and fibrillar Aβ burden. We investigated how metabolic and Aβ measurements, in respective clusters of preferentially affected voxels, are related to each other. MMPLS was used in “informed mode” for the simultaneous analysis of fluorodeoxyglucose (FDG) and Pittsburgh Compound B (PiB) positron emission tomography (PET) images from 11 ∊4 homozygotes, 11 ∊4 heterozygotes, and 16 ∊4 noncarriers who were cognitive normal (65 ± 5 years old). Patterns of cerebral-to-whole brain FDG PET counts and cerebral-to-cerebellar PiB Distribution Volume Ratios (DVRs) most closely associated with APOE ∊4 gene dose were characterized. ∊4 homozygote, heterozygote, and non-carrier groups did not differ significantly in their age, gender distribution, educational level, Mini-Mental State Examination scores (29.6 ± 0.8), or Auditory Verbal Learning Test long-term memory scores. Patterns most closely associated with APOE ∊4 gene dose were notable for lower glucose metabolism in the precuneus and posterior cingulate cortex and increased fibrillar Aβ in the precuneus, posterior cingulate cortex and medial prefrontal cortex. As expected, there was a strong correlation between lower cerebral glucose metabolism and higher fibrillar Aβ in respective empirically defined statistical regions-of-interest (comprised of voxels associated with ∊4 gene dose at p≤0.005) in all 38 subjects (r = -0.46, p = 0.0039) and in the 22 ∊4 carriers (r = -0.47, p = 0.028). Larger sample sizes are needed to further characterize the relationships for each APOE genotype. There is a strong relationship between the pattern of regional hypometabolism and fibrillar Aβ deposition associated with three levels of genetic risk for late-onset AD in cognitively normal adults.

Association Between Higher Fasting Serum Glucose Levels and the Pattern of Lower Regional Gray Matter Volumes in Cognitively Normal Adults

Investigating the Association Between Fasting Serum Glucose Levels and Cerebral Metabolic Rate for Glucose in Brain Regions Affected by Alzheimer's Disease

Higher Serum Glucose Levels Are Associated with Cerebral Hypometabolism in Alzheimer Regions

Association Between Longitudinal Increases in Serum Glucose and Metabolic Decline in Azheimer’s Disease-Related Brain Regions (P6.321)

Longitudinal Changes in Serum Glucose Levels Are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions

Association Between Cerebral Patterns of Fibrillar Beta-Amyloid Burden and Glucose Hypometabolism in Cognitively Normal Older Adults at Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease

Association of impaired fasting glucose and Type 2 Diabetes Mellitus with brain volume changes in Alzheimer’s Disease patients analyzed by MRI: a retrospective study

Elevated blood glucose levels are associated with the progression of brain hypometabolism, and HDL-C and APOE4 add to this association

Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers

Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading

Fasting Blood Glucose and Cerebrospinal Fluid Alzheimer's Biomarkers in Non-Diabetic Cognitively Normal Elders: the CABLE Study.

Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE Ɛ3/ɛ4 Carriers.

Higher Serum Total Cholesterol Levels in Late Middle Age Are Associated with Glucose Hypometabolism in Brain Regions Affected by Alzheimer'S Disease and Normal Aging

P2‐243: Higher BMI is Associated with Greater Cerebral Glucose Metabolism in Late Middle‐Aged and Elderly Subjects Regardless of APOE Ε4 Genotype

Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease.

Brain imaging evidence of preclinical Alzheimer's disease in normal aging

Associations Between Glucose Metabolism Measures and Amyloid-β and Tau Load on PET 14 Years Later: Findings From the Framingham Heart Study

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

P3‐119: Higher blood glucose is associated with dementia among Chinese elderly independent of vascular risk factors and white matter hyperintensity volume: findings from SCOBHI

Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment

High normal fasting blood glucose is associated with dementia in Chinese elderly